Mitral Valve Prolapse
36
11
12
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.8%
1 terminated out of 36 trials
91.7%
+5.2% vs benchmark
3%
1 trials in Phase 3/4
36%
4 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (36)
Arrhythmic Mitral Valve Prolapse Detection Using Long-term Ambulatory Rhythm Monitoring
The Role of cardIac magNeTic rEsonance in surGical Decision Making in Patients With Severe pRimAry miTral rEgurgitation
Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse
AI-Based Shape and Function Analysis of Mitral Valve Prolapse Using 3D Ultrasound
Ventricular Arrhythmias in Patients Undergoing Mitral Valve Surgery
PRIMARY Ancillary Substudy
Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse
Korea VHD Echo Study: Surveillance of Aortic, Mitral & Tricuspid Patients - Insights From Real-world Practice
A Study of Mitral Annular Disjunction in Mitral Valve Prolapse Patients and Arrhythmia Risk
Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse
CE Mark Study for the Harpoon Medical Device in Poland
Safety and Early Feasibility Study of the Harpoon Medical Device (EFS)
CE Mark Study for the Harpoon Medical Device
Genetic Basis of Mitral Valve Prolapse
Operative Mitral Valve Reconstruction in Functional mv Insufficiency With Reduced Systolic Ventricle Function
Prognostic Impact of the Location of Mitral Valve Prolapse on the Long-term Results of Mitral Plasty
Mitral Valve Prolapse, Arrhythmias and Mitral Valve Surgery
STretch and Myocardial Characterization in Arrythmogenic Mitral Valve Prolapse-2
European FIH Study - NeoChord Transcatheter Mitral Repair System for Symptomatic Mitral Regurgitation
Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse (STAMP: STretch and Myocardial Characterization in Arrhythmogenic Mitral Valve Prolapse)